Panel Q&A: Nicotine harm reduction – evidence and ethics
10:15 - 10:35
-
Evidence and Research
- What are the evidence gaps and how do we fill them – is it time for the WHO to review its advice on e-cigarettes?
- How should we distinguish between different categories of reduced harm nicotine products
- Are we any nearer identifying the ideal regulatory framework for e-cigarettes
Speakers
Deborah Arnott Chief Executive - Action on Smoking and Health (ASH)
Dr Karl E. Lund Senior Researcher - Norwegian Institute of Public Health
Prof Virginia Berridge Professor of History - London School of Hygiene and Tropical Medicine
Judith Watt International Tobacco Control Consultant
James Van Loon Director General, Tobacco Control Directorate - Health Canada
« Back to previous page